Total Payments
$2,430
2024 Payments
$34.43
Companies
26
Transactions
163
Medicare Patients
3,024
Medicare Billing
$219,787
Payment Breakdown by Category
Food & Beverage$2,408 (99.1%)
Education$22.51 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,408 | 161 | 99.1% |
| Education | $22.51 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $515.70 | 31 | $0 (2024) |
| Novo Nordisk Inc | $458.94 | 35 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $300.01 | 20 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $242.88 | 17 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $149.26 | 10 | $0 (2019) |
| Lilly USA, LLC | $148.07 | 10 | $0 (2019) |
| PFIZER INC. | $109.14 | 8 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $91.26 | 5 | $0 (2019) |
| GlaxoSmithKline, LLC. | $76.97 | 5 | $0 (2023) |
| Shire North American Group Inc | $41.85 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $34.43 | 2 | Amgen Inc. ($34.43) |
| 2023 | $164.75 | 8 | Amgen Inc. ($117.85) |
| 2022 | $44.63 | 2 | Amgen Inc. ($44.63) |
| 2021 | $91.71 | 5 | Amgen Inc. ($74.11) |
| 2020 | $169.60 | 11 | Amgen Inc. ($50.63) |
| 2019 | $604.99 | 44 | Novo Nordisk Inc ($181.41) |
| 2018 | $654.63 | 44 | Novo Nordisk Inc ($162.86) |
| 2017 | $665.75 | 47 | SANOFI-AVENTIS U.S. LLC ($209.35) |
All Payment Transactions
163 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Inflammation | ||||||
| 06/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Inflammation | ||||||
| 11/16/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Inflammation | ||||||
| 09/01/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Inflammation | ||||||
| 07/28/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Inflammation | ||||||
| 05/03/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Inflammation | ||||||
| 04/12/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/20/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Inflammation | ||||||
| 02/03/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Inflammation | ||||||
| 05/06/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Inflammation | ||||||
| 01/21/2022 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Neuroscience | ||||||
| 11/10/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $17.60 | General |
| Category: Cardiovascular | ||||||
| 10/13/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Neuroscience | ||||||
| 09/17/2021 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Neuroscience | ||||||
| 07/22/2021 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Neuroscience | ||||||
| 03/12/2021 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Neuroscience | ||||||
| 11/02/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Neuroscience | ||||||
| 07/20/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Neuroscience | ||||||
| 06/16/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Neuroscience | ||||||
| 03/10/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Diabetes | ||||||
| 03/03/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: RESPIRATORY | ||||||
| 02/26/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Diabetes | ||||||
| 02/11/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/04/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 551 | 716 | $115,426 | $47,332 |
| 2022 | 12 | 724 | 934 | $116,975 | $59,338 |
| 2021 | 15 | 1,133 | 1,447 | $119,914 | $66,328 |
| 2020 | 13 | 616 | 845 | $100,899 | $46,789 |
Total Patients
3,024
Total Services
3,942
Medicare Billing
$219,787
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 115 | 232 | $53,460 | $16,594 | 31.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 56 | 89 | $25,005 | $11,091 | 44.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 69 | 69 | $12,075 | $8,453 | 70.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 63 | 63 | $7,056 | $4,532 | 64.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 67 | $12,130 | $3,163 | 26.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 70 | 70 | $2,940 | $2,057 | 70.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 68 | 68 | $1,700 | $1,154 | 67.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 44 | 46 | $460.00 | $156.86 | 34.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 12 | $600.00 | $130.80 | 21.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 140 | 290 | $52,830 | $22,330 | 42.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 93 | 93 | $16,310 | $11,624 | 71.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 61 | 101 | $22,145 | $11,397 | 51.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 71 | 71 | $7,242 | $4,866 | 67.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 56 | 62 | $8,880 | $2,442 | 27.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 86 | 86 | $2,597 | $2,199 | 84.7% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 12 | 12 | $2,076 | $1,578 | 76.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 84 | 84 | $2,100 | $1,456 | 69.3% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 11 | 11 | $528.00 | $449.39 | 85.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 15 | 15 | $345.45 | $340.39 | 98.5% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 16 | 16 | $992.00 | $337.44 | 34.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 79 | 93 | $930.00 | $318.94 | 34.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 146 | 288 | $48,672 | $22,941 | 47.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 79 | 136 | $27,880 | $16,108 | 57.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 77 | 77 | $13,500 | $9,898 | 73.3% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 123 | 123 | $5,790 | $4,495 | 77.6% |
About Dr. Derek Olson, M.D
Dr. Derek Olson, M.D is a Sports Medicine healthcare provider based in Gaylord, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497796007.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Derek Olson, M.D has received a total of $2,430 in payments from pharmaceutical and medical device companies, with $34.43 received in 2024. These payments were reported across 163 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,408).
As a Medicare-enrolled provider, Olson has provided services to 3,024 Medicare beneficiaries, totaling 3,942 services with total Medicare billing of $219,787. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Sports Medicine
- Location Gaylord, MI
- Active Since 06/08/2006
- Last Updated 01/06/2021
- Taxonomy Code 207QS0010X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1497796007
Products in Payments
- Aimovig (Biological) $271.88
- FARXIGA (Drug) $179.09
- Otezla (Drug) $173.25
- Ozempic (Drug) $161.24
- Victoza (Drug) $149.17
- JANUVIA (Drug) $135.43
- TOUJEO (Drug) $120.38
- SOLIQUA (Drug) $114.29
- Tresiba (Drug) $92.31
- CHANTIX (Drug) $66.82
- SYMBICORT (Drug) $63.79
- STIOLTO (Drug) $50.62
- PRALUENT (Drug) $47.46
- EMGALITY (Drug) $45.09
- TRADJENTA (Drug) $42.34
- LYRICA (Drug) $42.32
- VYVANSE (Drug) $41.85
- STIOLTO RESPIMAT (Drug) $40.64
- Trintellix (Drug) $40.23
- TRELEGY ELLIPTA (Drug) $34.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.